Triazolam and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Triazolam (triazolam), especially for people who are female, 30-39 old, also take Bactrim Ds, and have High blood pressure.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Triazolam. It is created by eHealthMe based on reports of 5,701 people who have side effects when taking Triazolam from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 941 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

5,701 people reported to have side effects when taking Triazolam.
Among them, 14 people (0.25%) have Thrombophlebitis.

Among these 14 people:

What is the gender of people who have Thrombophlebitis when taking Triazolam? *

female: 100 %
male: 0.0 %

What is the age of people who have Thrombophlebitis when taking Triazolam? *

What are other drugs people take besides Triazolam? *

What are other side effects people have besides Thrombophlebitis? *

Blood Alkaline Phosphatase Increased: 12 people, 85.71%
Vestibular Disorder (disorders of the body's balance (vestibular) system in the inner ear): 10 people, 71.43%
Resorption Bone Increased: 10 people, 71.43%
Glaucoma (increased fluid pressure in the eye with vision loss): 10 people, 71.43%
High Blood Cholesterol: 10 people, 71.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 71.43%
Neuropathy Peripheral (surface nerve damage): 10 people, 71.43%
Purpura Senile (skin condition in which areas of the skin develop a purplish or reddish-brown appearance due to bleeding of small blood vessels underneath): 10 people, 71.43%
Tarsal Tunnel Syndrome (a condition that is caused by compression of the tibial nerve or its associated branches as the nerve): 10 people, 71.43%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 71.43%

What are the existing conditions these people have? *

Muscle Spasms (muscle contraction): 9 people, 64.29%
High Blood Pressure: 9 people, 64.29%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 21.43%
Depression: 3 people, 21.43%
Pain: 2 people, 14.29%
Multiple Allergies (allergy to multiple agents): 2 people, 14.29%
Hypersensitivity: 2 people, 14.29%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 14.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 14.29%
Stress And Anxiety: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triazolam:

Triazolam (5,838 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (941 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triazolam (the active ingredients of Triazolam) and Triazolam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.